Pharm
Ceftazidime-Avibactam
search
Ceftazidime-Avibactam
, Zavicefta, Avycaz
See Also
Third Generation Anti-Pseudomonal Cephalosporin
Ceftazidime
Cephalosporin
Indications
See
Third Generation Anti-Pseudomonal Cephalosporin
Conditions
Gram-Negative, Multi-drug resistant intraabdominal Infections and
Urinary Tract Infection
s
No anaerobic coverage (add
Metronidazole
for abdominal infections)
Pseudomonas
infections
Pseudomonas Osteochondritis
Cystic Fibrosis
lung infection
Ventilator-Associated Pneumonia
Ceftazidime
Bacteria
l Coverage
Pseudomonas
aeruginosa (Main indication)
EKP Gram Negative Bacteria
(
Escherichia coli
,
Klebsiella
,
Proteus
)
ESP Gram Negative Bacteria
(
Enterobacter
,
Serratia
,
Providencia
)
Also covers
Citrobacter
species
Gram Positive Cocci
poorly covered
No
Gram Negative Coccobacilli
coverage
Avibactam additional activity
Addition of
Beta-Lactamase
inhibitor (Avibactam) circumvents
Beta-Lactamase
resistance
Pharmacokinetics
Half-Life
Ceftazidime
: 2.7 hours (similar for Avibactam)
Ceftazidime
is excreted in urine (80-90% unchanged, avibactam is 100% unchanged on excretion)
Adjust dose in
Renal Failure
Medications
Avycaz 2.5 g
Ceftazidime
2 g
Avibactam 0.5 g
Dosing
Adult
GIve 2.5 g IV every 8 hours (infused over 2 hours)
Duration
Urinary Tract Infection
s: Treat for 7 to 14 days
Intraabdominal infections: Treat for 5 to 14 days
Combine with
Metronidazole
Renal Dosing
eGFR 31 to 50 ml/min
Give 1.25 g IV every 8 hours
eGFR 16 to 30 ml/min
Give 0.94 g IV every 12 hours
eGFR 6 to 15 ml/min
Give 0.94 g IV every 24 hours
eGFR <5 ml/min
Load 0.94 g IV every 48 hours (after
Hemodialysis
)
Dosing
Child
Age 6 months to 18 years
GIve 62.5 mg/kg (max 2.5 g) IV every 8 hours (infused over 2 hours)
Age 3 to 6 months
GIve 50 mg/kg IV every 8 hours (infused over 2 hours)
Renal Dosing
eGFR 31 to 50 ml/min
Give 31.25 mg/kg (max 1.25 g) IV every 8 hours
eGFR 16 to 30 ml/min
Give 23.75 mg/kg (max 0.94 g) IV every 12 hours
eGFR 6 to 15 ml/min
Give 23.75 mg/kg (max 0.94 g) IV every 24 hours
eGFR <5 ml/min
Give 23.75 mg/kg (max 0.94 g) IV every 48 hours (after
Hemodialysis
)
Safety
Avoid Avibactam in pregnancy (adverse effects in pregnancy)
Unknown safety in
Lactation
Ceftazidime
is excreted in
Breast Milk
Efficacy
Limited spectrum (focused
Gram Negative
bacillus and
Pseudomonas
coverage)
Adverse Effects
Gastrointestinal (
Nausea
,
Vomiting
,
Diarrhea
,
Constipation
)
Dizziness
Anxiousness
Abdominal Pain
Paresthesia
s
Resources
Ceftazidime-Avibactam (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd
References
Morrison and LoVecchio (2021) Crit Dec Emerg Med 35(1): 28
Matesanz (2021) Rev Esp Quimioter 34 Suppl 1(Suppl1):38-40 +PMID: 34598423 [PubMed]
Type your search phrase here